How much funding has Cogenesys raised?

Cogenesys has raised $55.0M in total funding, most recently a Series A round.

Who are Cogenesys's investors?

Cogenesys's investors include New Enterprise Associates.

Where is Cogenesys headquartered?

Cogenesys is headquartered in Rockville, Maryland, United States.

Cogenesys

Acquired

Rockville, United States · Founded 2006 · $55.0M raised

Biotech

Headquarters: Rockville, Maryland
Founded: 2006
Business Model: B2B

Total Funding: $55.0M
Last Round: $55.0M Series AJun 2006
Rounds: 1

About

CoGenesys was a Rockville, Maryland-based biopharmaceutical company focused on the discovery and development of peptide- and protein-based medicines. The company built a pipeline of biotherapeutics targeting cancer, cardiovascular disease, metabolic disorders, infectious diseases, autoimmune conditions, and central nervous system diseases. CoGenesys employed peptide and protein engineering technologies to advance a portfolio of novel therapeutic candidates from discovery through clinical development. The company was founded in 2005 and raised a $55 million Series A funding round in July 2006 led by New Enterprise Associates.

Summary

Cogenesys is a Biotech company based in Rockville, United States, founded in 2006. It has raised $55.0M in total across 1 round, most recently a $55.0M Series A round in Jun 2006. Investors include New Enterprise Associates.